|
Volumn 255, Issue SUPPL.3, 2008, Pages 7-11
|
The role of IVIg in autoimmune neuropathies: The latest evidence
|
Author keywords
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP); Guillain Barr syndrome (GBS); IVIg
|
Indexed keywords
HUMAN IMMUNOGLOBULIN;
IMMUNOGLOBULIN;
PLACEBO;
AUTOIMMUNE DISEASE;
CLINICAL TRIAL;
COCHRANE LIBRARY;
CONFERENCE PAPER;
DEMYELINATING NEUROPATHY;
DISABILITY;
DISEASE SEVERITY;
DRUG CHOICE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
GUILLAIN BARRE SYNDROME;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
LOADING DRUG DOSE;
MAINTENANCE THERAPY;
MOTOR NEUROPATHY;
MULTIFOCAL MOTOR NEUROPATHY;
NEUROPATHY;
PLASMAPHERESIS;
POLYRADICULONEUROPATHY;
PRIORITY JOURNAL;
RELAPSE;
UNSPECIFIED SIDE EFFECT;
CLINICAL TRIALS AS TOPIC;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOTHERAPY;
PERIPHERAL NERVOUS SYSTEM DISEASES;
POLYRADICULONEUROPATHY;
POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;
TREATMENT OUTCOME;
|
EID: 49249131318
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-008-3003-z Document Type: Conference Paper |
Times cited : (20)
|
References (21)
|